Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Drug Combination as a Pharmacotherapeutic for Methamphetamine-Use Disorder

NCT04178993 is registered in ClinicalTrials.gov with Craig Rush as lead sponsor.

NCT NCT04178993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04178993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Drug Combination as a Pharmacotherapeutic for Methamphetamine-Use Disorder
Lead sponsor
Craig Rush
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2019
Completion date
May 5, 2021
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine use disorder